Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00052338
What this trial is testing

Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00654758
What this trial is testing

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AbbVie 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487
What this trial is testing

NDI 1150-101 in Patients With Solid Tumors

Who this might be right for
Solid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Nimbus Saturn, Inc. 106
Not applicableStudy completedNCT00827333
What this trial is testing

Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
City of Hope Medical Center 372
Large-scale testing (Phase 3)Study completedNCT00322452
What this trial is testing

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 1,329
Early research (Phase 1)Study completedNCT00250978
What this trial is testing

Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT00625352
What this trial is testing

Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ulsan University Hospital 48
Early research (Phase 1)UnknownNCT05430009
What this trial is testing

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Who this might be right for
Liver MetastasesNon-small Cell Lung Cancer
VA Ann Arbor Healthcare System 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699721
What this trial is testing

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage ⅢANon-small Cell Lung Cancer Stage IIIB
Xiangya Hospital of Central South University 60
Not applicableStudy completedNCT02010047
What this trial is testing

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients

Who this might be right for
Nonsmall Cell Lung Cancer
British Columbia Cancer Agency 166
Testing effectiveness (Phase 2)UnknownNCT06331455
What this trial is testing

Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection

Who this might be right for
Lung Cancer PatientsNon-small Cell Lung Cancer (NSCLC)
Marc de Perrot 12
Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Large-scale testing (Phase 3)Active Not RecruitingNCT06311721
What this trial is testing

Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Amgen 315
Early research (Phase 1)Study completedNCT00683904
What this trial is testing

Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
R-Pharm 12
Testing effectiveness (Phase 2)UnknownNCT05007938
What this trial is testing

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 30
Not applicableStudy completedNCT04529564
What this trial is testing

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT02581787
What this trial is testing

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
Maximilian Diehn 28
Testing effectiveness (Phase 2)Looking for participantsNCT06084806
What this trial is testing

Test-retest Evaluation of [18F]F-AraG PET

Who this might be right for
Non-small Cell Lung Cancer
CellSight Technologies, Inc. 10
Next Page